Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERIN Trial
NCT00476619Phase 4Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2004
- Primary completion
- Nov 2007
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in contrast-induced nephropathy (CIN) comparing Erythropoietin with Placebo (2 arms). Primary endpoint: Incidence of rise in serum creatinine of 25% or more at 7 days. Started Sep 2004; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00476619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476619.